Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,440
Closed -$228K 405
2023
Q3
$228K Hold
2,440
0.04% 315
2023
Q2
$314K Hold
2,440
0.05% 271
2023
Q1
$297K Hold
2,440
0.06% 255
2022
Q4
$259K Buy
+2,440
New +$268K 0.06% 274
2022
Q2
Sell
-2,692
Closed -$344K 364
2022
Q1
$344K Buy
2,692
+12
+0.4% +$1.31K 0.06% 278
2021
Q4
$360K Hold
2,680
0.06% 273
2021
Q3
$374K Hold
2,680
0.07% 259
2021
Q2
$328K Hold
2,680
0.08% 213
2021
Q1
$283K Hold
2,680
0.07% 232
2020
Q4
$248K Buy
+2,680
New +$239K 0.11% 177

Other funds holding DXCM

Intrua Financial's DXCM Position: Q4 2023 in Review

Intrua Financial sold out of DexCom (DXCM) in Q4 2023, closing a stake of 2,440 shares — an estimated $228K sold.

Intrua Financial first reported a position in DXCM in Q4 2020 and held it in 10 quarters. The position peaked at $374K in Q3 2021. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Intrua Financial reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Intrua Financial sold 2,440 DexCom shares in Q4 2023, an estimated $228K.
  • Intrua Financial first reported a position in DexCom in Q4 2020 and held it in 10 quarters.
  • Intrua Financial's DexCom position peaked at $374K in Q3 2021.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Intrua Financial's 13F filing for Q4 2023, filed 28 May 2025.